Up to $1.6 M is available in R&D funding for Victorian SME Health solutions providers.
The Health MVP is a $15 million competitive grants program that encourages innovation in healthcare. Through the Health MVP, the Victorian Government is seeking solutions to healthcare challenges in order to achieve better health outcomes, improve healthcare service delivery and deliver economic benefits for Victoria.
The following Feasibility Study projects are underway and due to be delivered in 2013. Follow the links for more information on each of the participating SMEs.
Successfully completed Feasibility Studies will be assessed for further funding of up to $1.5million over two years for the Validation stage to undertake R&D (including clinical trials) to further progress the solution.
The Health MVP objectives are to:
For Victorian public sector entities the Health MVP provides support to identify problems and collaborate with industry to develop solutions that will improve health or healthcare service delivery and reduce costs.
For SMEs the Health MVP provides a new source of funding to develop products, processes or services and the opportunity to develop and validate new technology in response to a real customer demand. This provides a sound position to secure further investment and/or commercial opportunities.
The Victorian community will benefit from:
The Health MVP Feasibility Study aims to determine and document the viability of the solution proposed by the SME. The study will be undertaken by the SME, and provides the opportunity to develop the partnership between the Host and the SME.
In preparing to commence the Feasibility Study, the Host and SME will establish and agree on governance arrangements to support the objectives of the study and ensure that the Feasibility Study Report comprehensively details the activity and outcomes of the study.
The main steps in undertaking a Feasibility Study are:
SMEs approved to undertake Feasibility Study will enter into a funding agreement of up to $100,000 with the Host to develop a Feasibility Study Report. The funding agreement will include the terms of the funding, monitoring, evaluation and reporting processes required to ensure that the project is well managed between the Host and the SME.
The Host will administer and acquit the funding and manage the development and completion of the Feasibility Study in accordance with the terms of the funding agreement.
The key milestones for the Feasibility Study are:
SMEs that progress to Validation will enter into a new funding agreement. Health MVP funding of up to $1.5 million per project over a period of up to two years will be made available (granted from DBI to the Host) to SMEs to conduct the R&D project. The funding agreement will include the terms of the funding, monitoring, evaluation, agreed milestones and deliverables required by DBI to ensure that the project is well managed between the Host and SME.
The Host will administer the funding and manage the development and completion of the Validation stage in accordance with the terms of the funding agreement.
To be eligible, SME applicants must meet the following eligibility requirements:
Writing a good quality grant application is a critical element in the application process. An application needs to be well thought through, written concisely, have clear objectives and purpose, and show clear links to the objectives of the grant guidelines.
The grant application must answer all questions, provide all required information and respond to the merit criteria. It should also reflect your organisation’s business strategy.
Writing a good application takes time and effort, and requires particular writing skills.
Bulletpoint are expert grant consultants and can assist with all aspects of grant preparation.
Call us on (03) 9005 6789 or email to discuss further.
We can assist with demonstrating:
Absorbable rib prosthesis – Ingeneus will work with Alfred Health to investigate a rib fixation prosthesis as well as the instruments needed for use in chest trauma surgery.
Portable body movement sensor – Procept will work with Austin Health to investigate a movement analysis device for the management of patients with complex movement disorders from neurological conditions such as stroke, Parkinson’s disease and traumatic brain injury.
Antibiotic delivery system – Osprey Medical will work with Melbourne Health’s Diabetic Foot Unit to investigate a means of delivering an infusion of antibiotics to the tree of the leg with minimal escape of the drug into the patient’s circulation system.
Pharmacogenomic decision support system – Genes FX will work with Melbourne Health’s Department of Clinical Pharmacology and Therapeutics to investigate a personalised drug safety system that can be integrated into current hospital practices.
Beneficial re-use of biosolids – Earth Systems will work with Melbourne Water to investigate sustainable and beneficial uses of biosolids including recovery of valuable products, reduced volumes of waste, reduced operational costs through on-site energy generation and reduced greenhouse gas emissions.
Algae biomass to biogas - Algae Enterprises will work with Melbourne Water to investigate the production of biogas from algae biomass grown in wastewater for renewable energy generation.
Smart sensors for large diameter water pipes - Hawk Measurement will work with Melbourne Water to investigate low-cost, reliable and durable methods of attaching existing sensor technology to large diameter pressure water pipes, and connecting fibre optic sensors between pipelines to form a network of fibre sensors that will provide early warning of faults or defects.
Infant feeding teat – APS Innovations will work with the Royal Children’s Hospital to investigate cost-effective prototypes of a range of infant feeding teats designed to meet the specific requirements of both healthy and difficult feeders.
Ophthalmic Outreach Diagnostic Platform - Ingeneus will work with the Royal Victorian Eye & Ear Hospital to investigate an easy-to-use slit lamp and tonometer for the assessment of eye health by a GP, in particular the diagnosis of glaucoma.
Vehicle On-board Unit Auditing Station - Cohda Wireless will work with VicRoads to investigate a freight on-board unit auditing and monitoring station that operates with both the Intelligent Access Program and existing tag technology.
Interactive Patient Journey Board - Alcidion will work with Western Health to investigate a product that gives real-time information on the current status of all patients within the health service.
Passive Stormwater Treatment Technology – Enviro Stream Solutions will work with Yarra Valley Water to investigate a practical water treatment product that allows pathogens to be removed from stormwater, which can then be used for non-drinking purposes such as garden, laundry and toilet flushing.
Ten innovative Victorian companies have been awarded funding of up to $100,000 to undertake feasibility studies as part of the Health Market Validation Program – a $15 million competitive grants program designed to encourage innovation in healthcare.
Minister for Technology Gordon Rich-Phillips said the companies had been awarded funding under the feasibility study stage of the program to investigate whether new technologies can solve healthcare challenges identified by Victorian hospitals and health services.
“The Health Market Validation Program supports collaboration between the public health sector, researchers and companies and is an initiative of Victoria’s Technology Plan for the Future – Biotechnology,” Mr Rich-Phillips said.
“The program aims to improve health services for Victorians and capitalise on Victoria’s strength as the leading state for medical research and innovation, to create commercial and export opportunities for Victorian companies.
“Under the first stage, we sought challenges in areas such as dental, reproductive, emergency and children’s health, and we then went to market seeking Victorian companies to propose solutions to these problems.
“Once successfully completed, the feasibility studies will be assessed for further funding for the validation stage to undertake R&D to develop solutions over two years,” Mr Rich-Phillips said.
Companies receiving funding of up to $100,000 to carry out feasibility studies are: